Research ArticleTheranostics
Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
Ingo Einspieler, Isabel Rauscher, Charlotte Düwel, Markus Krönke, Christoph Rischpler, Gregor Habl, Sabrina Dewes, Armin Ott, Hans-Jürgen Wester, Markus Schwaiger, Tobias Maurer and Matthias Eiber
Journal of Nuclear Medicine July 2017, 58 (7) 1081-1087; DOI: https://doi.org/10.2967/jnumed.116.184457
Ingo Einspieler
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
2Department of Radiology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Isabel Rauscher
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Charlotte Düwel
3Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Markus Krönke
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Christoph Rischpler
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Gregor Habl
4Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Sabrina Dewes
4Department of Radiation Oncology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Armin Ott
5Institute of Medical Statistics and Epidemiology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Hans-Jürgen Wester
6Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany; and
Markus Schwaiger
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Tobias Maurer
3Department of Urology, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
Matthias Eiber
1Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany
7Department of Molecular and Medical Pharmacology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 58, Issue 7
July 1, 2017
Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
Ingo Einspieler, Isabel Rauscher, Charlotte Düwel, Markus Krönke, Christoph Rischpler, Gregor Habl, Sabrina Dewes, Armin Ott, Hans-Jürgen Wester, Markus Schwaiger, Tobias Maurer, Matthias Eiber
Journal of Nuclear Medicine Jul 2017, 58 (7) 1081-1087; DOI: 10.2967/jnumed.116.184457
Detection Efficacy of Hybrid 68Ga-PSMA Ligand PET/CT in Prostate Cancer Patients with Biochemical Recurrence After Primary Radiation Therapy Defined by Phoenix Criteria
Ingo Einspieler, Isabel Rauscher, Charlotte Düwel, Markus Krönke, Christoph Rischpler, Gregor Habl, Sabrina Dewes, Armin Ott, Hans-Jürgen Wester, Markus Schwaiger, Tobias Maurer, Matthias Eiber
Journal of Nuclear Medicine Jul 2017, 58 (7) 1081-1087; DOI: 10.2967/jnumed.116.184457
Jump to section
Related Articles
Cited By...
- A 2022 International Survey on the Status of Prostate Cancer Theranostics
- 18F-rhPSMA-7 PET for the Detection of Biochemical Recurrence of Prostate Cancer After Curative-Intent Radiation Therapy: A Bicentric Retrospective Study
- Predictors of 18F-DCFPyL PET/CT Positivity in Patients with Biochemical Recurrence of Prostate Cancer After Local Therapy
- Bridging the Imaging Gap: PSMA PET/CT Has a High Impact on Treatment Planning in Prostate Cancer Patients with Biochemical Recurrence--A Narrative Review of the Literature
- Metaanalysis of 68Ga-PSMA-11 PET Accuracy for the Detection of Prostate Cancer Validated by Histopathology